VICENTINI, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 13.628
EU - Europa 10.261
AS - Asia 4.513
Continente sconosciuto - Info sul continente non disponibili 30
SA - Sud America 29
OC - Oceania 13
AF - Africa 11
Totale 28.485
Nazione #
US - Stati Uniti d'America 13.609
IE - Irlanda 2.676
IT - Italia 2.504
CN - Cina 2.247
TR - Turchia 2.094
DE - Germania 1.110
SE - Svezia 1.028
UA - Ucraina 973
GB - Regno Unito 905
FI - Finlandia 511
FR - Francia 383
IN - India 109
RU - Federazione Russa 32
EU - Europa 28
CH - Svizzera 23
NL - Olanda 20
BE - Belgio 19
IL - Israele 18
BR - Brasile 17
CA - Canada 14
RO - Romania 14
KR - Corea 12
AU - Australia 11
ES - Italia 8
IR - Iran 6
AR - Argentina 5
AT - Austria 5
HU - Ungheria 5
MX - Messico 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
VN - Vietnam 5
AL - Albania 4
MD - Moldavia 4
RS - Serbia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
GR - Grecia 3
JP - Giappone 3
MA - Marocco 3
NG - Nigeria 3
PE - Perù 3
PL - Polonia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
BD - Bangladesh 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
HR - Croazia 2
IQ - Iraq 2
LU - Lussemburgo 2
NZ - Nuova Zelanda 2
QA - Qatar 2
SA - Arabia Saudita 2
SM - San Marino 2
TW - Taiwan 2
ZA - Sudafrica 2
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
EC - Ecuador 1
EG - Egitto 1
HK - Hong Kong 1
IM - Isola di Man 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LV - Lettonia 1
ME - Montenegro 1
PH - Filippine 1
PY - Paraguay 1
SG - Singapore 1
UZ - Uzbekistan 1
Totale 28.485
Città #
Jacksonville 3.831
Dublin 2.673
Chandler 2.585
Izmir 1.085
San Mateo 792
Nanjing 767
Boardman 749
Wilmington 562
Lawrence 483
Princeton 483
New York 342
Milan 337
Ann Arbor 255
Nanchang 248
Shenyang 173
Verona 172
Seattle 150
Ashburn 142
Mountain View 133
Tianjin 131
Rome 129
Hebei 126
Jiaxing 119
Kunming 111
Beijing 108
Woodbridge 94
Bremen 79
Des Moines 73
Norwalk 68
Jinan 65
Changsha 64
Zhengzhou 55
Ningbo 50
Hangzhou 47
L'aquila 47
Falls Church 45
Naples 45
Helsinki 34
Lanzhou 34
Philadelphia 33
Taizhou 28
Bologna 27
Shanghai 26
Turin 24
Guangzhou 23
Palermo 23
Torino 23
Changchun 20
Fremont 20
Los Angeles 20
Pune 19
Dearborn 18
Florence 18
Brussels 17
Catania 16
Düsseldorf 15
Genoa 15
Napoli 15
Padova 15
Perugia 12
Trento 12
Strasbourg 11
Dallas 10
Tappahannock 10
Torre Del Greco 10
Brescia 9
Pavia 9
Torrevecchia Teatina 9
Anguillara Veneta 8
Favara 8
Fuzhou 8
Houston 8
Monza 8
Redmond 8
Treviolo 8
Cosenza 7
Hanover 7
Livorno 7
Miglianico 7
Palagiano 7
Auburn Hills 6
Belfast 6
Hefei 6
Lioni 6
London 6
Pescara 6
Piacenza 6
Reggio Calabria 6
Toronto 6
Villamagna 6
Bari 5
Boulder 5
Budapest 5
Cesena 5
Iesi 5
Jesi 5
Modena 5
Montecosaro 5
Paris 5
Pisa 5
Totale 18.194
Nome #
INCONTINENZA URINARIA DA STRESS IN PAZIENTE CON MIASTENIA GRAVIS: DESCRIZIONE DI UN CASO CLINICO 1.072
LA “CORONA MORTIS”: UN PROBLEMA PER LA CHIRURGIA PROTESICA UROGINECOLOGICA? 524
STENT URETERALE CON ANIMA METALLICA SPIRALIFORME: SICUREZZA IN RISONANZA MAGNETICA NUCLEARE 285
SINDROME DEL TERATOMA CRESCENTE: PRESENTAZIONE DI UN CASO CLINICO 150
The daily therapy with silodosin can have a role in the treatment of "life-long" premature ejaculation 132
ANTIANDROGENS AND 5-ALPHA REDUCTASE INHIBITION OF THE PROLIFERATION RATE IN PC3 AND DU145 HUMAN PROSTATIC-CANCER CELL-LINES 103
Tumor-stroma metabolic relationship based on lactate shuttle can sustain prostate cancer progression 102
Testicular changes after treatment with a GnRH analog (Buserelin) in association with cyproterone acetate in men with prostatic cancer 99
STENT URETERALE A DIMORA DA CIRCA 9 ANNI IN PAZIENTE MONORENE FUNZIONALE SINISTRO: DESCRIZIONE DI UN CASO CLINICO 94
Serum 25(OH)D seasonality in urologic patients from central Italy 90
Antiproliferative and pro-apoptotic effects of 5-azacytidine in prostate carcinoma cells in vitro involve the recovering of PTEN-mediated Akt activity control and androgen sensitivity 89
THE PROSTATIC MASSAGE YELDS VIABLE PROSTATIC EPITHELIAL CELLS AND MAY ALLOW AND EARLY DIAGNOSIS OF PROSTATIC CANCER IN VITRO 89
Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro 88
IMPATTO ATTUALE DELL’ECOGRAFIA PROSTATICA TRANSRETTALE NELLA DIAGNOSI DEL TUMORE DELLA PROSTATA 87
Valutazione clinica della Norfloxacina nel trattamento delle infezioni urinarie basse non complicate. 86
An unusual case of massive funicular lipoma 85
Unilateral sling transection for patients with postoperative voiding dysfunction after transobturator sling surgery 85
Trattamento con Casodex ed Iressa nel tumore della prostata: evidenze biologiche a favore 84
Urodynamic characterization of a female population with clinical SUI and concomitant symptoms suggestive of bladder outlet obstruction 82
Obesity in the elderly - On the role of adipokines in prostate cancer progression 80
PROTEASE PRODUCTION (Upa AND METALLOPROTEINASES MMP-9) IN SHORT TERM CULTURE OF PROSTATIC CARCINOMA, CAN HAVE IMPORTANT DIAGNOSTIC AND PROGNOSTIC IMPLICATIONS. 80
[Recurrence and survival in 30 partial resections of bladder neoplasms. Critical review of the cases]. FT Studio delle recidive e della sopravvivenza in 30 resezioni parziali della vescica per neoplasia. Revisione critica della casistica. 79
Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors 79
Human prostatic carcinoma in tissue culture: Correlations between histological diagnosis and in vitro parameters 79
Urodynamic parameters after solifenacin treatment in men with overactive bladder symptoms and detrusor underactivity 78
Leptin contributes to long-term stabilization of HIF-1α in cancer cells subjected to oxygen limiting conditions 78
Combination treatment with solifenacin and tamsulosin in men with overactive bladder (OAB) and bladder outlet obstruction (BOO) 77
Between-subject variations of transition zone epithelial volume and serum PSA levels in men with benign prostatic hyperplasia 77
Tissue print of prostate biopsy: a novel tool in the diagnostic procedure of prostate cancer 77
MODIFIED SCHEME OF NEOADJUVANT CHEMOTHERAPY (MVC) FOR INVASIVE TRANSITIONAL CELL CARCINO-MA OF THE BLADDER: A PHASE I STUDY 77
Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cells 77
Imipenem concentrations in human prostatic tissue: Clinical implications 77
Precisazioni sul legamento anulare del collo del piede 76
INTERNET E LA DIDATTICA INTEGRATA NEL POST-LAUREA 76
UTILIZZO DELL’ENERGIA BIPOLARE PLASMACINETICA NELLE NEOPLASIE VESCICALI: SICUREZZA DELLA RESEZIONE OSTIALE E OUTCOMES CHIRURGICI 76
Arachidonic acid modulates the crosstalk between prostate carcinoma and bone stromal cells 75
Anatomical findings on the behavior of Pectoralis Major muscle fibers 75
Effects of mepartricin on clinical and functional parameters in benign prostatic hypertrophy 75
UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) AND METALLOPROTEINASE (MMP-9) PRODUCTION IS IN-CREASED IN SHORT TERM CULTURES OF HUMAN PROSTATIC CARCINOMA. 75
Fibrotecoma del testicolo: descrizione di un raro caso clinico 75
Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitro 75
Finasteride for benign prostatic hyperplasia 75
Early diagnosis of prostatic carcinoma based on in vitro culture of viable tumor cells harvested by prostatic massage 73
Female Sexual Function Evaluation of the Tension-Free Vaginal Tape (TVT) and Transobturator Suburethral Tape (TOT) Incontinence Surgery: Results of a Prospective Study Editorial Comment 73
A prospective study of the safety and efficacy of suprapubic transvesical prostatectomy in patients with benign prostatic hyperplasia 73
L'acido valproico è un potente induttore di apoptosi nelle linee di carcinoma prostatico 73
La ridondanza delle vie di segnalazione intracellulari PI3K-AKT-MTOR induce la resistenza di cellule di cancro prostatico alla terapia ormonale ed ai chemoterapici in vivo ed in vitro 73
LA BIOPSIA TRANSMURALE: STAGING REALE DEL CARCINOMA VESCICALE 73
LA RESEZIONE TRANSURETRALE DI PROSTATA NEL PAZIENTE IPOCONTRATTILE: NOSTRA ESPERIENZA 73
Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines 73
Gefitinib and bicalutamide show synergistic effects in primary cultures of prostate cancer derived from androgen-dependent naive patients 73
APOPTOSI E CANCRO DELLA PROSTATA 73
Urodynamic Obstruction in Women With Stress Urinary Incontinence-Do Nonintubated Uroflowmetry and Symptoms Aid Diagnosis? 73
Valproic acid induces apoptosis in prostate carcinoma cell lines by activation of multiple death pathways 72
Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination 72
[Unusual complication of percutaneous pyelostomy]. FT Insolita complicanza in tema di pielostomia percutanea. 72
[Details concerning the anterior annular ligament of the instep]. FT Istituto di Anatomia Umana Normale dell'Istituto Universitario di Medicina e Chirurgia di L'Aquila. 72
Transobturator surgery in presence of corona mortis: a study in 13 women 72
Sexual function in women with urinary incontinence treated by pelvic floor transvaginal electrical stimulation 72
Aging influences the Value of Serum Leptin as Prostate Cancer Risk Factor 72
ESTABLISHMENT AND CHARACTERIZATION OF A HUMAN PROSTATIC-CARCINOMA CELL STRAIN OBTAINED FROM EXFOLIATED TUMOR-CELLS AFTER PROSTATIC MASSAGE 71
In vitro study of Human Dermal Fibroblasts seeded on two kinds of surgical meshes: Monofilamented Polypropylene and multifilamented Polyestere 71
Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samples 71
Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma 71
RUOLO DELLA TERAPIA DI ASSOCIAZIONE DAPOXETINA (30 MG)-TADALAFIL (5 MG) NEL TRATTAMENTO DELL’EIACULAZIONE PRECOCE “LIFELONG”: NOSTRA ESPERIENZA 71
Bicalutamide increases phospho-Akt levels through Her2 in patients with prostate cancer 71
Akt protein expression and activation in naive and antihormonal treated prostate cancer tissues 71
Effetto di Getifinib sulla crescita e la formazione di metastasi nel tumore della prostata in vivo 71
A reduced dosage of MVC (methotrexate, vinblastine, cisplatin) intravenously in the treatment of invasive bladder carcinoma 71
Transperineal versus transrectal prostate biopsy for predicting the final laterality of prostate cancer: are they reliable enough to select patients for focal therapy? Results from a multicenter international study 71
Imaging of medullary sponge kidney: notes for urologists 70
Short-term tissue culture of prostatic carcinoma samples provides useful biological parameters related to patient prognosis 70
Arachidonic acid sustains prostate tumor growth in bone metastasis through the COX-2-mediated production of TNF-alpha 69
A new inhibitor of EGFR/SRC activation is able to block several key molecular events in prostate cancer progression 69
INHIBITION OF 5-ALPHA-REDUCTASE ISOFORMS IN PROSTATE CARCINOMA PRIMARY CULTURES 69
Tamsulosin treatment increases clinical success rate of single extracorporeal shock wave lithotripsy of renal stones 69
THE IMPACT OF SERUM LEPTIN AS BIOMARKER OF PROSTATE CANCER INCREASES WITH AGEING 69
Determination of imipenem in human plasma, urine and tissue by high-performance liquid chromatography 68
Percutaneous treatment of varicocele: considerations and our experience. 68
LOCAL IMMUNOTHERAPY OF SUPERFICIAL BLADDER-CANCER BY INTRAVESICAL INSTILLATION OF RECOMBINANT INTERLEUKIN-2 68
Brain activations in patients with psychogenic erectile dysfunction: An fMRI study 68
Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cells 67
In vivo efficacy of HER1/EGFR tyrosine kinase inhibition in erlotinib resistant PC3 prostate cancer cells is associated to reduced endothelial cell organization and increased inflammatory infiltration 67
[The Studer orthotopic ileal neobladder: patient compliance]. FT Neovesciche ileali ortotopiche sec. Studer: "compliance" del paziente. 67
Moderne vedute sulla circolazione arteriosa del duodeno 67
Approccio transotturatorio multiple nel trattamento chirurgico dei prolassi urogenitali completi: Risultati preliminari su riproducibilità e sicurezza 66
Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells 66
Reactivation of androgen receptor and Fas: FASL signalling pathways by azacitidine treatment sensitizes aggressive prostate cancers to hormone manipulation and chemotherapy 66
Detrusor overactivity increases bladder wall thickness in male patients: A urodynamic multicenter cohort study 66
Does transrectal color Doppler ultrasound improve the diagnosis of prostate cancer? 65
FINASTERIDE DOSE-DEPENDENCY REDUCES THE PROLIFERATION RATE OF THE LNCAP HUMAN PROSTATIC-CANCER CELL-LINE IN-VITRO 65
TIME-COURSE STUDY OF PYY AND ENTEROGLUCAGON RELEASE AFTER ILEAL RESECTION IN MAN 65
UN POSSIBILE TRATTAMENTO PER L’EIACULAZIONE PRECOCE: LA TERAPIA DI COMBINAZIONE. 65
L'aumento di neurotrofine è associato alla progressione del tumore della prostata in un modello animale murino 65
[International prostate symptom score: comparison of doctor and patient]. FT International prostate symptom score: medico e paziente a confronto. 65
Correlation between anamnesis and urodynamics in non-neurogenic female urinary incontinence | [CORRELAZIONE FRA ANAMNESI ED URODINAMICA NELL'INCONTINENZA URINARIA FEMMINILE NON NEUROGENA] 64
Anti-hormone treatments increase Akt protein expression and activation in prostate cancer 64
Bombesin-dependent Pro-MMP-9 activation in Prostatic Cancer cells requires beta-1 integrin engagement 64
Reduction of prostate-specific antigen after tamsulosin treatment in patients with elevated prostate-specific antigen and lower urinary tract symptoms associated with low incidence of prostate cancer at biopsy 64
LA RIDONDANZA DELLE VIE DI SEGNALAZIONE INTRACELLULARI PI3K-AKT-MTOR INDUCE LA RESISTENZA DI CELLULE DI CANCRO PROSTATICO ALLA TERAPIA ORMONALE ED A CHEMOTERAPICI IN VIVO ED IN VITRO 64
Totale 9.210
Categoria #
all - tutte 86.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.198


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.662 0 0 0 0 0 0 0 0 0 0 164 1.498
2019/20203.773 874 12 514 30 29 526 654 29 499 65 23 518
2020/20214.152 59 502 28 522 530 154 545 39 534 149 955 135
2021/20222.764 136 389 401 173 129 50 53 175 198 70 204 786
2022/20238.245 598 232 97 744 1.020 930 57 549 3.499 82 272 165
2023/20242.060 389 117 130 442 131 445 104 208 25 66 3 0
Totale 28.629